Pharmaceutical preparations company · DE · FY ends Dec · 4.94% margin · $105M FCF
Operating margin is thin at 4.94%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (FY)
$190M
Net Income (TTM)
$96M
▲ +111.9% YoY
Op. Margin
4.94%
ROIC
14.43%
▲ +66.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$105M
▲ +167.4% YoY
Op. Cash Flow (TTM)
$106M
▲ +167.7% YoY
Net Debt
-$201M
Net Cash Position
Cash & Equiv.
$256M
Continue Research